CLIA Kit for Inhibin B (INHB) Mus musculus (Mouse) Competition CLIA

INH-B

Add to Cart Distributors
Overview
Properties
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • CLIA Kit for Inhibin B (INHB) Packages (Simulation)
  • CLIA Kit for Inhibin B (INHB) Packages (Simulation)
  • CLIA Kit for Inhibin B (INHB) Results demonstration
  • CCA760Mu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Recovery

Matrices listed below were spiked with certain level of recombinant Inhibin B (INHB) and the recovery rates were calculated by comparing the measured value to the expected amount of Inhibin B (INHB) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-97 90
EDTA plasma(n=5) 96-104 101
heparin plasma(n=5) 93-104 99

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Inhibin B (INHB) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Inhibin B (INHB) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Inhibin B (INHB) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-102% 78-91% 98-105% 97-104%
EDTA plasma(n=5) 78-95% 80-96% 89-101% 89-97%
heparin plasma(n=5) 87-101% 78-92% 85-99% 90-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1 Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Reagent Diluent 1×300µL Stop Solution 1×6mL
TMB Substrate 1×9mL Instruction manual 1
Wash Buffer (30 × concentrate) 1×20mL

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
7. Read RLU value immediately.

CLIA Kit for Inhibin B (INHB)

Test principle

The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Inhibin B (INHB). A competitive inhibition reaction is launched between biotin labeled Inhibin B (INHB) and unlabeled Inhibin B (INHB) (Standards or samples) with the pre-coated antibody specific to Inhibin B (INHB). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Inhibin B (INHB) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Inhibin B (INHB) level in the sample or standard.

Citations

  • Are anti-MĂźllerian hormone and its receptor polymorphism associated with the hormonal condition of undescended testes?Pubmed:27162065
  • Gestational and lactational exposure to bisphenol AF in maternal rats increases testosterone levels in 23-day-old male offspring.pubmed:27567155
  • Overexpression of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in boys with cryptorchidismPubmed:29401475
  • Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian …Pubmed:29859107
  • Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the …Pubmed: 30606243
  • Diabetes Type 1 Negatively Influences Leydig Cell Function in Rats, Which is Partially Reversible By Insulin Treatment33507237

Recommend products